Diabetes-metabolism Research and Reviews

Diabetes/Metabolism Research and Reviews is a Wiley journal published under its present title since 1999, continuing Diabetes/Metabolism Reviews, which was launched in 1985, and covering clinical and basic advances in diabetes, obesity and metabolism, with a 2025 Journal Impact Factor of 8.3 and a first quartile rank of 15 of 198 in endocrinology and metabolism《糖尿病/代谢研究与评论》（Diabetes/Metabolism Research and Reviews）是（Wiley）出版的期刊，1999 年起用现名，延续 1985 年创刊的（Diabetes/Metabolism Reviews），覆盖糖尿病、肥胖与代谢的临床与基础进展，2025 年影响因子为 8.3，在内分泌与代谢类 198 种期刊中列第 15 位，居第一四分位。

Scope

• The journal publishes clinical and basic scientific advances in key areas of diabetes, obesity and metabolism该刊刊载糖尿病、肥胖与代谢等重点领域的临床与基础科学进展。
• Important historical overviews, discussion of controversial issues and opinions from prominent researchers and clinicians are published该刊刊载重要的历史性综述、争议问题的讨论，以及知名研究者与临床专家的观点。
• Basic science content includes the immunology and genetics of diabetes, islet biology and metabolic mechanisms基础科学内容涵盖糖尿病的免疫学与遗传学、胰岛生物学与代谢机制。
• Clinical content includes diagnosis, treatment, complications and prevention of diabetes and related metabolic disorders临床内容涵盖糖尿病及相关代谢疾病的诊断、治疗、并发症与预防。
• Epidemiological studies, systematic reviews and meta-analyses on diabetes and metabolism are within scope糖尿病与代谢的流行病学研究、系统综述与荟萃分析也在收录范围内。
• Each issue carries a current-awareness service summarising recent literature in diabetes for readers每期设有文献速览栏目，为读者概述糖尿病领域的近期文献。
• As a hybrid journal it publishes by subscription while offering an open access option to authors作为混合期刊，该刊以订阅方式出版，同时为作者提供开放获取选项。

History

• The journal began in 1985 as Diabetes/Metabolism Reviews, published by Wiley in New York and appearing quarterly by 1998该刊 1985 年以（Diabetes/Metabolism Reviews）创刊，由（Wiley）在纽约出版，至 1998 年为季刊。
• Its founding editor was Gerald M. Reaven, who led the journal until 1992, and he was followed by Domenico Andreani from 1993 to 1999创刊主编为（Gerald M. Reaven），任职至 1992 年；其后（Domenico Andreani）于 1993 至 1999 年接任。
• The title was renamed Diabetes/Metabolism Research and Reviews in 1999, continuing the earlier journal's volume numbering from volume 151999 年更名为（Diabetes/Metabolism Research and Reviews），自第 15 卷起延续原刊卷次。
• The journal appears bimonthly in electronic form, and print issues ceased with volume 26 in 2010, after which the journal has been online only该刊以电子形式双月出版，纸质版于 2010 年第 26 卷后停印，此后仅在线发行。
• It is published by Wiley, the successor to Wiley-Blackwell, and remains part of the company's life sciences portfolio该刊现由（Wiley）出版，其前身为（Wiley-Blackwell），仍属该公司生命科学出版序列。
• Its Journal Impact Factor reached 8.3 in 2025, ranking fifteenth among 198 journals in endocrinology and metabolism该刊 2025 年影响因子为 8.3，在内分泌与代谢类 198 种期刊中列第 15 位。

Editors

• The editor-in-chief is Paolo Pozzilli, who holds posts at the University Campus Bio-Medico of Rome in Italy and at the Blizard Institute of Barts and the London School of Medicine in the United Kingdom现任主编为（Paolo Pozzilli），任职于意大利（University Campus Bio-Medico of Rome）与英国（Blizard Institute, Barts and the London School of Medicine）。
• His research concerns the immunology and prevention of type 1 diabetes and the interface between metabolism and immunity其研究涉及 1 型糖尿病的免疫学与预防，以及代谢与免疫的交叉领域。
• Former editors-in-chief include Gerald M. Reaven, who shaped the journal's review tradition, and Domenico Andreani, who broadened its clinical base历任主编包括（Gerald M. Reaven），他奠定了该刊的综述传统；以及（Domenico Andreani），他拓展了期刊的临床基础。
• A journal manager, editorial assistant and content editor support the editor-in-chief in handling submissions and production期刊经理、编辑助理与内容编辑协助主编处理投稿与出版流程。
• The current-awareness section is compiled by the editorial team to summarise new literature for readers in diabetes research and practice文献速览栏目由编辑团队汇编，向糖尿病研究与临床读者概述新近文献。
• Manuscripts are submitted through the publisher's online system, are peer reviewed, and are handled by the editor-in-chief with associate editors by subject稿件经出版方在线系统提交并实行同行评审，由主编与按学科分工的副编辑处理。